• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型噬菌体vB_EfaS_HEf13对临床分离株具有广泛的裂解活性。

The Novel Phage vB_EfaS_HEf13 Has Broad Lytic Activity Against Clinical Isolates of .

作者信息

Lee Dongwook, Im Jintaek, Na Hongjun, Ryu Sangryeol, Yun Cheol-Heui, Han Seung Hyun

机构信息

Department of Oral Microbiology and Immunology, DRI, and BK21 Plus Program, School of Dentistry, Seoul National University, Seoul, South Korea.

Department of Agricultural Biotechnology, Research Institute for Agriculture and Life Sciences, Center for Food and Bioconvergence, Seoul National University, Seoul, South Korea.

出版信息

Front Microbiol. 2019 Dec 17;10:2877. doi: 10.3389/fmicb.2019.02877. eCollection 2019.

DOI:10.3389/fmicb.2019.02877
PMID:31921055
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6927925/
Abstract

is a Gram-positive, facultative anaerobic bacterium frequently found in the gastrointestinal tract, oral cavity, and periodontal tissue. Although it is considered a commensal, it can cause bacteremia, endocarditis, endodontic infections, and urinary tract infections. Because antibiotics are cytotoxic not only to pathogens, but also to health-beneficial commensals, phage therapy has emerged as an alternative strategy to specifically control pathogenic bacteria with minimal damage to the normal flora. In this study, we isolated a novel phage, phage vB_EfaS_HEf13 (phage HEf13), with broad lytic activity against 12 strains of among the three laboratory strains and 14 clinical isolates of evaluated. Transmission electron microscopy showed that phage HEf13 has morphological characteristics of the family . Phage HEf13 was stable at a wide range of temperature (4-60°C) and showed tolerance to acid or alkaline (pH 3-12) growth conditions. Phage HEf13 had a short latent period (25 min) with a large burst size (approximately 352 virions per infected cell). The lytic activity of phage HEf13 at various multiplicities of infection consistently inhibited the growth of diverse clinical isolates of without any lysogenic process. Moreover, phage HEf13 showed an effective lytic activity against on human dentin infection model. Whole genome analysis demonstrated that the phage HEf13 genome contains 57,811 bp of double-stranded DNA with a GC content of 40.1% and 95 predicted open reading frames (ORFs). Annotated functional ORFs were mainly classified into four groups: DNA replication/packaging/regulation, phage structure, host cell lysis, and additional functions such as RNA transcription. Comparative genomic analysis demonstrated that phage HEf13 is a novel phage that belongs to the lineage. Furthermore, the results of multiple sequence alignment showed that polymorphism of phage infection protein of (PIP) contributes to determine the host specificity of phage HEf13 against various strains. Collectively, these results suggest that phage HEf13 has characteristics of a lytic phage, and is a potential therapeutic agent for treatment or prevention of -associated infectious diseases.

摘要

是一种革兰氏阳性兼性厌氧菌,常见于胃肠道、口腔和牙周组织。尽管它被认为是共生菌,但它可引起菌血症、心内膜炎、牙髓感染和尿路感染。由于抗生素不仅对病原体具有细胞毒性,而且对有益健康的共生菌也有影响,噬菌体疗法已成为一种替代策略,可在对正常菌群造成最小损害的情况下特异性控制病原菌。在本研究中,我们分离出一种新型噬菌体,噬菌体vB_EfaS_HEf13(噬菌体HEf13),对评估的3株实验室菌株和14株临床分离株中的12株具有广泛的裂解活性。透射电子显微镜显示噬菌体HEf13具有该噬菌体科的形态特征。噬菌体HEf13在较宽的温度范围(4-60°C)内稳定,并且对酸性或碱性(pH 3-12)生长条件具有耐受性。噬菌体HEf13潜伏期短(25分钟),裂解量较大(每个感染细胞约352个病毒粒子)。噬菌体HEf13在不同感染复数下的裂解活性持续抑制各种临床分离株的生长,且无任何溶原过程。此外,噬菌体HEf13在人牙本质感染模型上对具有有效的裂解活性。全基因组分析表明,噬菌体HEf13基因组包含57,811 bp的双链DNA,GC含量为40.1%,预测有95个开放阅读框(ORF)。注释的功能性ORF主要分为四组:DNA复制/包装/调控、噬菌体结构、宿主细胞裂解以及RNA转录等其他功能。比较基因组分析表明噬菌体HEf13是一种属于该噬菌体谱系的新型噬菌体。此外,多序列比对结果表明,粪肠球菌噬菌体感染蛋白(PIP)的多态性有助于确定噬菌体HEf13对各种粪肠球菌菌株的宿主特异性。总体而言,这些结果表明噬菌体HEf13具有裂解性噬菌体的特征,是治疗或预防粪肠球菌相关传染病的潜在治疗剂。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e57/6927925/9c7a6fc0e55e/fmicb-10-02877-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e57/6927925/2ea4aa35abab/fmicb-10-02877-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e57/6927925/8fb2b46205e5/fmicb-10-02877-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e57/6927925/75274244df80/fmicb-10-02877-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e57/6927925/239c94cc8e2f/fmicb-10-02877-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e57/6927925/77c304cedb0e/fmicb-10-02877-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e57/6927925/d9b50f9f7af5/fmicb-10-02877-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e57/6927925/812ec6e460fb/fmicb-10-02877-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e57/6927925/9c7a6fc0e55e/fmicb-10-02877-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e57/6927925/2ea4aa35abab/fmicb-10-02877-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e57/6927925/8fb2b46205e5/fmicb-10-02877-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e57/6927925/75274244df80/fmicb-10-02877-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e57/6927925/239c94cc8e2f/fmicb-10-02877-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e57/6927925/77c304cedb0e/fmicb-10-02877-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e57/6927925/d9b50f9f7af5/fmicb-10-02877-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e57/6927925/812ec6e460fb/fmicb-10-02877-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e57/6927925/9c7a6fc0e55e/fmicb-10-02877-g008.jpg

相似文献

1
The Novel Phage vB_EfaS_HEf13 Has Broad Lytic Activity Against Clinical Isolates of .新型噬菌体vB_EfaS_HEf13对临床分离株具有广泛的裂解活性。
Front Microbiol. 2019 Dec 17;10:2877. doi: 10.3389/fmicb.2019.02877. eCollection 2019.
2
Enterococcus Phage vB_EfaS_HEf13 as an Anti-Biofilm Agent Against Enterococcus faecalis.肠球菌噬菌体 vB_EfaS_HEf13 作为抗粪肠球菌生物膜剂。
J Microbiol. 2024 Aug;62(8):683-693. doi: 10.1007/s12275-024-00150-z. Epub 2024 Jun 27.
3
Fully Characterized Effective Bacteriophages Specific against Antibiotic-Resistant , the Causative Agent of Dental Abscess.针对导致牙龈脓肿的抗生素耐药菌,全面鉴定有效的噬菌体。
Medicina (Kaunas). 2024 Mar 19;60(3):501. doi: 10.3390/medicina60030501.
4
vB_EfaS-DELF1, a novel Siphoviridae bacteriophage with highly effective lytic activity against vancomycin-resistant Enterococcus faecalis.vB_EfaS-DELF1,一种新型的肌尾噬菌体科噬菌体,对耐万古霉素粪肠球菌具有高效裂解活性。
Virus Res. 2021 Jun;298:198391. doi: 10.1016/j.virusres.2021.198391. Epub 2021 Mar 15.
5
Characterization and genome analysis of novel phage vB_EfaP_IME195 infecting Enterococcus faecalis.新型噬菌体vB_EfaP_IME195感染粪肠球菌的特性及基因组分析
Virus Genes. 2018 Dec;54(6):804-811. doi: 10.1007/s11262-018-1608-6. Epub 2018 Nov 1.
6
Characterization and Anti-Biofilm Activity of Lytic Enterococcus Phage vB_Efs8_KEN04 against Clinical Isolates of Multidrug-Resistant in Kenya.肯尼亚产溶肠球菌噬菌体 vB_Efs8_KEN04 的特性及其抗多药耐药临床分离株的生物膜活性
Viruses. 2024 Aug 9;16(8):1275. doi: 10.3390/v16081275.
7
Bacteriophages to Control Multi-Drug Resistant Infection of Dental Root Canals.用于控制牙根根管多重耐药感染的噬菌体
Microorganisms. 2021 Mar 3;9(3):517. doi: 10.3390/microorganisms9030517.
8
Potential application of phage vB_EfKS5 to control Enterococcus faecalis and its biofilm in food.噬菌体vB_EfKS5在控制食品中粪肠球菌及其生物膜方面的潜在应用。
AMB Express. 2023 Nov 20;13(1):130. doi: 10.1186/s13568-023-01628-6.
9
Isolation, characterization, and comparative genomic analysis of a phage infecting high-level aminoglycoside-resistant (HLAR) .一种感染高水平氨基糖苷类耐药菌(HLAR)的噬菌体的分离、特性鉴定及比较基因组分析
PeerJ. 2020 May 21;8:e9171. doi: 10.7717/peerj.9171. eCollection 2020.
10
Characterization of the Bacteriophage vB_EfaS-271 Infecting .描述. 噬菌体 vB_EfaS-271 的特性
Int J Mol Sci. 2020 Sep 1;21(17):6345. doi: 10.3390/ijms21176345.

引用本文的文献

1
Encapsulation of a Novel Bacteriophage into Chitosan-alginate Microspheres as a Delivery System to Prevent Oral Diseases.将新型噬菌体封装到壳聚糖-海藻酸盐微球中作为预防口腔疾病的递送系统。
J Glob Infect Dis. 2025 Jun 26;17(2):93-97. doi: 10.4103/jgid.jgid_171_24. eCollection 2025 Apr-Jun.
2
Synergistic efficacy of phages along with vancomycin for eradication of vancomycin-resistant biofilms.噬菌体与万古霉素联合用于根除耐万古霉素生物膜的协同疗效。
World J Virol. 2025 Jun 25;14(2):95826. doi: 10.5501/wjv.v14.i2.95826.
3
A novel thermostable lytic phage vB_EF_Enf3_CCASU-2024-3 against clinical Enterococcus faecium and Enterococcus faecalis.

本文引用的文献

1
Evaluation of Phage Therapy in the Context of and Its Associated Diseases.噬菌体治疗在 和相关疾病方面的评估。
Viruses. 2019 Apr 20;11(4):366. doi: 10.3390/v11040366.
2
Lactobacillus plantarum Lipoteichoic Acid Inhibits Oral Multispecies Biofilm.植物乳杆菌脂磷壁酸抑制口腔多物种生物膜。
J Endod. 2019 Mar;45(3):310-315. doi: 10.1016/j.joen.2018.12.007.
3
Countermeasures Defeat a Virulent Bacteriophage.抗击烈性噬菌体的对策。
一种新型的针对临床粪肠球菌和屎肠球菌的耐热性裂解噬菌体vB_EF_Enf3_CCASU-2024-3。
AMB Express. 2025 Apr 26;15(1):65. doi: 10.1186/s13568-025-01871-z.
4
Novel strategies for vancomycin-resistant Enterococcus faecalis biofilm control: bacteriophage (vB_EfaS_ZC1), propolis, and their combined effects in an ex vivo endodontic model.耐万古霉素粪肠球菌生物膜控制的新策略:噬菌体(vB_EfaS_ZC1)、蜂胶及其在体外牙髓模型中的联合作用。
Ann Clin Microbiol Antimicrob. 2025 Apr 13;24(1):24. doi: 10.1186/s12941-025-00790-y.
5
Potential of a phage cocktail in the treatment of multidrug-resistant Klebsiella pneumoniae pulmonary infection in mice.噬菌体鸡尾酒疗法治疗小鼠耐多药肺炎克雷伯菌肺部感染的潜力
BMC Microbiol. 2025 Mar 17;25(1):151. doi: 10.1186/s12866-025-03851-6.
6
Therapeutic potential of a newly isolated bacteriophage against multi-drug resistant Enterococcus faecalis infections: in vitro and in vivo characterization.一种新分离的噬菌体对耐多药粪肠球菌感染的治疗潜力:体外和体内特性研究
BMC Microbiol. 2025 Feb 20;25(1):80. doi: 10.1186/s12866-025-03785-z.
7
From Isolation to Application: Utilising Phage-Antibiotic Synergy in Murine Bacteremia Model to Combat Multidrug-Resistant Enterococcus faecalis.从分离到应用:在小鼠菌血症模型中利用噬菌体 - 抗生素协同作用对抗耐多药粪肠球菌
Microb Biotechnol. 2025 Jan;18(1):e70075. doi: 10.1111/1751-7915.70075.
8
Phage therapy as an alternative strategy for oral bacterial infections: a systematic review.噬菌体疗法作为口腔细菌感染的替代策略:一项系统综述
BMC Oral Health. 2025 Jan 8;25(1):44. doi: 10.1186/s12903-024-05399-9.
9
Bacteriophage Therapy as a Promising Alternative for Antibiotic-Resistant : Advances and Challenges.噬菌体疗法作为抗生素耐药性的一种有前景的替代方法:进展与挑战
Antibiotics (Basel). 2024 Nov 23;13(12):1120. doi: 10.3390/antibiotics13121120.
10
Characteristics of the Enterococcus Phage vB_EfS_SE, and the Properties of Its Chimeric Endolysins Harboring a PlySE-Carbohydrate-Binding Domain and a Synthetic Enzymatic Domain.粪肠球菌噬菌体vB_EfS_SE的特性及其嵌合内溶素的特性,该嵌合内溶素含有PlySE碳水化合物结合结构域和合成酶结构域。
Pharmaceutics. 2024 Oct 9;16(10):1312. doi: 10.3390/pharmaceutics16101312.
Viruses. 2019 Jan 10;11(1):48. doi: 10.3390/v11010048.
4
A Wake-Up Call: We Need Phage Therapy Now.敲响警钟:我们现在就需要噬菌体疗法。
Viruses. 2018 Dec 5;10(12):688. doi: 10.3390/v10120688.
5
Characterization and genome analysis of novel phage vB_EfaP_IME195 infecting Enterococcus faecalis.新型噬菌体vB_EfaP_IME195感染粪肠球菌的特性及基因组分析
Virus Genes. 2018 Dec;54(6):804-811. doi: 10.1007/s11262-018-1608-6. Epub 2018 Nov 1.
6
Characterization of Bacteriophages Infecting Clinical Isolates of .感染……临床分离株的噬菌体的特性分析 。(原文此处不完整)
Front Microbiol. 2018 Jul 31;9:1701. doi: 10.3389/fmicb.2018.01701. eCollection 2018.
7
Development and Validation of a Microtiter Plate-Based Assay for Determination of Bacteriophage Host Range and Virulence.基于微孔板的噬菌体宿主范围和毒力测定方法的建立与验证。
Viruses. 2018 Apr 12;10(4):189. doi: 10.3390/v10040189.
8
Identification and Characterization of T5-Like Bacteriophages Representing Two Novel Subgroups from Food Products.代表食品中两个新亚群的类T5噬菌体的鉴定与特性分析。
Front Microbiol. 2018 Feb 13;9:202. doi: 10.3389/fmicb.2018.00202. eCollection 2018.
9
Subchronic Oral Dose Toxicity Study of (EF 2001) in Mice.(EF 2001)对小鼠的亚慢性经口剂量毒性研究。
Toxicol Res. 2018 Jan;34(1):55-63. doi: 10.5487/TR.2018.34.1.055. Epub 2018 Jan 15.
10
Effectiveness of a Lytic Phage SRG1 against Vancomycin-Resistant in Compost and Soil.溶菌噬菌体 SRG1 对堆肥和土壤中耐万古霉素的有效性。
Biomed Res Int. 2017;2017:9351017. doi: 10.1155/2017/9351017. Epub 2017 Sep 24.